Electromed, Inc. (ELMD) Comparison with companies in other sectors?

Electromed, Inc. has a share price of 8.39M. You can analyze Electromed, Inc. (ELMD) competitors across different market sectors through stock heatmaps.

What are ELMD's NET and operating margins?

Electromed, Inc. (ELMD) operating margin is around 0.15, and net profit margin is approximately 0.12 as of the latest reports.

In what way does ELMD's earnings per share (EPS) trend reflect its financial momentum?

Electromed, Inc. (ELMD) EPS is 0.79 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Electromed, Inc. is 23.86, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Electromed, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Electromed, Inc. like P/E which is 22.21, P/B which is 3.62, and PEG which is 3.42. Compare them with sector averages to evaluate if the stock is priced fairly.

Electromed, Inc.

ELMD•AMEX

Healthcare

Medical - Devices

$18.82

$0.18(0.97%)

Fundamental Analysis of Electromed, Inc. (ELMD)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$0.79

P/E Ratio

23.86

ROE

0.17%

Net Margin

0.12%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$158.08M

Shares OutstandingTotal number of shares issued

$8.39M

Book Value/ShareNet worth per share

$5.17

Revenue/ShareAnnual revenue per share

$7.23

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.79

Net MarginNet income as percentage of revenue

11.66%

Operating MarginOperating income as percentage of revenue

14.58%

ROEReturn on shareholders' equity

16.50%

ROAReturn on total assets

13.65%

ROCEReturn on capital employed

20.38%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.40

Cash/ShareCash and equivalents per share

$1.79

FCF YieldFree cash flow as percentage of market cap

7.55%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for ELMDFinancial Ratios Analysis details for ELMD are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for ELMDSector Benchmarking details for ELMD are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Electromed, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Electromed, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Electromed, Inc.'s unique business strengths and challenges.

Key Financial Metrics for Electromed, Inc.

For Electromed, Inc., essential financial indicators include EPS 0.79, PE 23.86, and ROE 0.17. These key ratios reveal insights into Electromed, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Electromed, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Electromed, Inc.

Metrics like Net Margin 11.66% and ROA 13.65% shed light on how well Electromed, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Electromed, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Electromed, Inc.

Using ratios such as P/B Ratio 3.62 and PEG Ratio 3.42, investors can assess whether Electromed, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Electromed, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Electromed, Inc.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow $1.40, provide a snapshot of Electromed, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Electromed, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Electromed, Inc.

Investing in Electromed, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Electromed, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;